Q2 Earnings: Sun Pharma consolidated profit rises 5%, beats estimates
Pharma major Sun Pharma posted a 5 percent year-on-year (YoY) rise in its consolidated net profit to ₹2,375.5 crore for the July-September quarter versus ₹2,262.22 crore in the same period last year.
Meanwhile, its revenue rose over 11 percent YoY to ₹12,192 crore in the quarter under review as against ₹10,952.3 crore in the year-ago period.
The firm beat Street estimates on both the profit as well as revenue front.
Earnings before interest, taxes, depreciation, and amortization (EBITDA), for the quarter, rose nearly 8 percent on year to ₹3,179.30 crore, but operating margin contracted by 91 basis points to 26.08 percent.
(This is a developing story)
“Exciting news! Mint is now on WhatsApp Channels ???? Subscribe today by clicking the link and stay updated with the latest financial insights!” Click here!
Download The Mint News App to get Daily Market Updates.
Updated: 01 Nov 2023, 01:50 PM IST
